StockData
Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc. (PHAT) stock

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30
$5.50−0.38 (-6.46%)

Close on Nov 17, 2026Market cap $447.10MP/E –Yield –

Phathom Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Phathom Pharmaceuticals's gross margin for the twelve months ending Sep 30, 2026 was 80.7%. For fiscal 2025 it was 87.1%, against 85.6% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202587.1%+1.5
FY2024Dec 31, 202485.6%+10.1
FY2023Dec 31, 202375.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202678.3%−9.2
Q2 FY2026Jun 30, 202679.7%−7.6
Q1 FY2026Mar 31, 202679.4%−7.5
Q4 FY2025Dec 31, 202586.7%−0.4
Q3 FY2025Sep 30, 202587.5%+1.9
Q2 FY2025Jun 30, 202587.2%+6.0
Q1 FY2025Mar 31, 202586.9%+9.2
Q4 FY2024Dec 31, 202487.1%+11.6
Q3 FY2024Sep 30, 202485.6%–
Q2 FY2024Jun 30, 202481.2%–
Q1 FY2024Mar 31, 202477.7%–
Q4 FY2023Dec 31, 202375.5%–

More Phathom Pharmaceuticals figures

See a number that looks wrong?